Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial-Reference-Cited by-同舟云学术

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

Published:2017-12 Issue:10111 Volume:390 Page:2481-2489
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Green Ari J,Gelfand Jeffrey M,Cree Bruce A,Bevan Carolyn,Boscardin W John,Mei Feng,Inman Justin,Arnow Sam,Devereux Michael,Abounasr Aya,Nobuta Hiroko,Zhu Alyssa,Friessen Matt,Gerona Roy,von Büdingen Hans Christian,Henry Roland G,Hauser Stephen L,Chan Jonah R

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Multiple sclerosis–the plaque and its pathogenesis;Frohman;N Engl J Med,2006

2. Regulation of oligodendrocyte differentiation and myelination;Emery;Science,2010

3. Cells of the oligodendroglial lineage, myelination, and remyelination;Miron;Biochim Biophys Acta,2011

4. Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo;Czopka;Dev Cell,2013

Cited by 413 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosynthesis of the benzylpyrrolidine precursor in anisomycin by a unique ThDP-dependent enzyme;Synthetic and Systems Biotechnology;2025

2. Retinal Damage and Visual Network Reconfiguration Defines Visual Function Recovery in Optic Neuritis;Neurology Neuroimmunology & Neuroinflammation;2024-11

3. RXR agonist, 9-cis-13,14-dihydroretinoic acid (9CDHRA), reduces damage and protects from demyelination in transsynaptic degeneration model;Neuroscience;2024-11

4. Effects of disease-modifying therapies on remyelination in multiple sclerosis; evaluation via visual evoked potential test;Multiple Sclerosis and Related Disorders;2024-11

5. Overview of emerging therapies for demyelinating diseases;World Journal of Clinical Cases;2024-10-26